BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8784863)

  • 1. Neurochemical mechanisms underlying responses to psychostimulants.
    Volkow ND; Fowler JS; Hitzemann R; Wang GJ
    NIDA Res Monogr; 1996; 159():322-48. PubMed ID: 8784863
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; Hitzemann R; Chen AD; Dewey SL; Pappas N
    Nature; 1997 Apr; 386(6627):830-3. PubMed ID: 9126741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical predictors and correlates of vulnerability to cocaine use.
    King RJ; Flowers C
    NIDA Res Monogr; 1996; 159():228-63; discussion 264-8. PubMed ID: 8784861
    [No Abstract]   [Full Text] [Related]  

  • 4. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.
    Schlaepfer TE; Pearlson GD; Wong DF; Marenco S; Dannals RF
    Am J Psychiatry; 1997 Sep; 154(9):1209-13. PubMed ID: 9286178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological mechanisms in cocaine and opiate dependence.
    Koob GF
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():79-92. PubMed ID: 1311123
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to cocaine addiction.
    Dackis CA; Gold MS
    J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine abuse: neurochemistry, phenomenology, and treatment.
    Gold MS; Washton AM; Dackis CA
    NIDA Res Monogr; 1985; 61():130-50. PubMed ID: 3932873
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine reward and cocaine craving: the role of dopamine in perspective.
    Wise RA
    NIDA Res Monogr; 1994; 145():191-206. PubMed ID: 8742814
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and repeated cocaine induces alterations in FosB/DeltaFosB expression in the paraventricular nucleus of the hypothalamus.
    Chocyk A; Czyrak A; Wedzony K
    Brain Res; 2006 May; 1090(1):58-68. PubMed ID: 16674926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central stimulant abuse: neurochemistry and pharmacotherapy.
    Dackis CA; Gold MS; Pottash AL
    Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants].
    Herz A
    Nervenarzt; 1995 Jan; 66(1):3-14. PubMed ID: 7885510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine, dopamine and the endogenous opioid system.
    Kreek MJ
    J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 17. A neurocomputational model for cocaine addiction.
    Dezfouli A; Piray P; Keramati MM; Ekhtiari H; Lucas C; Mokri A
    Neural Comput; 2009 Oct; 21(10):2869-93. PubMed ID: 19635010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.
    Sossi V; Holden JE; Chan G; Krzywinski M; Stoessl AJ; Ruth TJ
    J Cereb Blood Flow Metab; 2000 Apr; 20(4):653-60. PubMed ID: 10779009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD
    Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast onset of dopamine uptake inhibition by intravenous cocaine.
    Mateo Y; Budygin EA; Morgan D; Roberts DC; Jones SR
    Eur J Neurosci; 2004 Nov; 20(10):2838-42. PubMed ID: 15548229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.